Paul Averback serves as Executive at NYMOX PHARMACEUTICAL CORP, where they oversee executive responsibilities. Since joining the company, Paul Averback has executed 2 insider transactions totaling $4.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 29, 2018 involved selling 1,687,600 shares valued at $4.2M.
Paul Averback currently holds 21,643,948 shares of NYMOX PHARMACEUTICAL CORP (NYMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Averback has been a net seller of NYMX stock. They have purchased $0 and sold $4.4M worth of shares.
Paul Averback's most recent insider trade was on Oct 29, 2018, when they sold 1,687,600 shares at $2.50 per share.
Get notified when new Form 4 filings are submitted
| $1.75 |
| Discretionary |